Alterna Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,550
Closed -$224K 115
2024
Q4
$224K Hold
1,550
0.19% 87
2024
Q3
$251K Hold
1,550
0.23% 79
2024
Q2
$227K Buy
+1,550
New +$231K 0.2% 96
2020
Q4
$401K Buy
2,545
+1,189
+88% +$175K 0.51% 50
2020
Q3
$202K Sell
1,356
-1,445
-52% -$214K 0.29% 72
2020
Q2
$394K Buy
+2,801
New +$408K 0.47% 46
2020
Q1
Sell
-1,890
Closed -$276K 95
2019
Q4
$276K Buy
1,890
+152
+9% +$20.6K 0.31% 69
2019
Q3
$225K Buy
1,738
+279
+19% +$36.8K 0.27% 85
2019
Q2
$203K Sell
1,459
-2
-0.1% -$277 0.24% 80
2019
Q1
$204K Sell
1,461
-29,040
-95% -$3.89M 0.17% 85
2018
Q4
$4.04M Buy
+30,501
New +$4.25M 0.66% 21

Other funds holding JNJ

Alterna Wealth Management's JNJ Position: Q1 2025 in Review

Alterna Wealth Management sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 1,550 shares — an estimated $224K sold.

Alterna Wealth Management first reported a position in JNJ in Q4 2018 and held it in 11 quarters. The position peaked at $4.04M in Q4 2018. 4,147 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Alterna Wealth Management reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
  • Alterna Wealth Management sold 1,550 Johnson & Johnson shares in Q1 2025, an estimated $224K.
  • Alterna Wealth Management first reported a position in Johnson & Johnson in Q4 2018 and held it in 11 quarters.
  • Alterna Wealth Management's Johnson & Johnson position peaked at $4.04M in Q4 2018.
  • 4,147 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Alterna Wealth Management's 13F filing for Q1 2025, filed 28 Apr 2025.